We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mastercard (MA) and HealthLock Unite to Reduce Medical Fraud
Read MoreHide Full Article
Mastercard Incorporated (MA - Free Report) partnered with HealthLock to protect millions of Americans from claim errors, medical bill frauds and overcharges. Healthcare expenditures are projected to reach $6.2 trillion by 2028, giving rise to more complexities and inefficiencies. This partnership aims to reduce complications and is expected to protect consumers' data and save costs.
This move bodes well for Mastercard, which is focused on protecting customer data and creating better security. Through this partnership, HealthLock’s analytics-based services can be used by millions of Mastercard users for no extra fee. In addition, the customers will also receive better rates for subscriptions and a free 90-day trial of HealthLock’s premium service.
Through HealthLocks’ unique value proposition, Mastercard will be able to retain issuer clients by enhancing its existing offerings. Mastercard issuers will benefit by gaining consumers’ trust as they ensure the privacy and security of medical data. As consumers save money on healthcare costs, as a byproduct of this move, issuers can drive incremental revenues and increase deposits.
Medical overbilling, abuse and fraud cost Americans $325 billion annually. Medical data fraud is on the rise and will continue to soar higher; hence consumers need to protect their data. As Mastercard collaborates with HealthLock, consumers are assisted in assessing every medical insurance claim and keeping them organized. More than half of the medical bills contain errors, and this move will help combat the same.
Mastercard has unmatchable experience in combating frauds and stands on its ground for innovation in data security. Mastercard’s partnership with HealthLock to enhance its technological footprint is likely to boost the top line in the future by adding value to the company’s existing offerings.
Price Performance
Shares of Mastercard have gained 12.9% in the past year compared with the industry’s growth of 5.2%.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Mastercard currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the Financial Transaction Services industry are PagSeguro Digital Ltd. (PAGS - Free Report) , Remitly Global, Inc. (RELY - Free Report) and Repay Holdings Corporation (RPAY - Free Report) . PagSeuro Digital sports a Zacks Rank #1 (Strong Buy), while Remitly Global and Repay Holdings carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The bottom line of PagSeguro Digital outpaced estimates in each of the trailing four quarters, the average surprise being 33%.
The Zacks Consensus Estimate for PAGS’s 2023 earnings suggests an improvement of 4.4%, while the same for revenues indicates growth of 8.1% from the corresponding year-ago reported figures.
Remitly Global’s bottom line outpaced estimates in two of the trailing four quarters while it missed the other two, the average surprise being 8.2%.
The Zacks Consensus Estimate for RELY’s 2023 revenues indicates a 36.8% rise from the prior-year reported figures.
The bottom line of Repay Holdings outpaced the Zacks Consensus Estimate in three of the trailing four quarters, while it missed once, the average surprise being 4.6%.
The Zacks Consensus Estimate for RPAY’s 2024 earnings indicates a 9.6% rise, while the same for revenues suggests 11.8% growth from the respective prior-year estimated figures.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Mastercard (MA) and HealthLock Unite to Reduce Medical Fraud
Mastercard Incorporated (MA - Free Report) partnered with HealthLock to protect millions of Americans from claim errors, medical bill frauds and overcharges. Healthcare expenditures are projected to reach $6.2 trillion by 2028, giving rise to more complexities and inefficiencies. This partnership aims to reduce complications and is expected to protect consumers' data and save costs.
This move bodes well for Mastercard, which is focused on protecting customer data and creating better security. Through this partnership, HealthLock’s analytics-based services can be used by millions of Mastercard users for no extra fee. In addition, the customers will also receive better rates for subscriptions and a free 90-day trial of HealthLock’s premium service.
Through HealthLocks’ unique value proposition, Mastercard will be able to retain issuer clients by enhancing its existing offerings. Mastercard issuers will benefit by gaining consumers’ trust as they ensure the privacy and security of medical data. As consumers save money on healthcare costs, as a byproduct of this move, issuers can drive incremental revenues and increase deposits.
Medical overbilling, abuse and fraud cost Americans $325 billion annually. Medical data fraud is on the rise and will continue to soar higher; hence consumers need to protect their data. As Mastercard collaborates with HealthLock, consumers are assisted in assessing every medical insurance claim and keeping them organized. More than half of the medical bills contain errors, and this move will help combat the same.
Mastercard has unmatchable experience in combating frauds and stands on its ground for innovation in data security. Mastercard’s partnership with HealthLock to enhance its technological footprint is likely to boost the top line in the future by adding value to the company’s existing offerings.
Price Performance
Shares of Mastercard have gained 12.9% in the past year compared with the industry’s growth of 5.2%.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Mastercard currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the Financial Transaction Services industry are PagSeguro Digital Ltd. (PAGS - Free Report) , Remitly Global, Inc. (RELY - Free Report) and Repay Holdings Corporation (RPAY - Free Report) . PagSeuro Digital sports a Zacks Rank #1 (Strong Buy), while Remitly Global and Repay Holdings carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The bottom line of PagSeguro Digital outpaced estimates in each of the trailing four quarters, the average surprise being 33%.
The Zacks Consensus Estimate for PAGS’s 2023 earnings suggests an improvement of 4.4%, while the same for revenues indicates growth of 8.1% from the corresponding year-ago reported figures.
Remitly Global’s bottom line outpaced estimates in two of the trailing four quarters while it missed the other two, the average surprise being 8.2%.
The Zacks Consensus Estimate for RELY’s 2023 revenues indicates a 36.8% rise from the prior-year reported figures.
The bottom line of Repay Holdings outpaced the Zacks Consensus Estimate in three of the trailing four quarters, while it missed once, the average surprise being 4.6%.
The Zacks Consensus Estimate for RPAY’s 2024 earnings indicates a 9.6% rise, while the same for revenues suggests 11.8% growth from the respective prior-year estimated figures.